These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26722539)
1. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy. Wu G; Jiang B; Liu X; Shen Y; Yang S Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539 [TBL] [Abstract][Full Text] [Related]
2. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer. Jia W; Sun JY; Jia KY; Liu XC Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763 [TBL] [Abstract][Full Text] [Related]
3. Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population. Xiao HL; Yang ZT; Han F; Wei HX Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173276 [TBL] [Abstract][Full Text] [Related]
4. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy. Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600 [TBL] [Abstract][Full Text] [Related]
5. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer. Zhao R; Chen G Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821 [TBL] [Abstract][Full Text] [Related]
6. Predictive potential role of GSTs gene polymorphisms in the treatment outcome of advanced non-small cell lung cancer patients. Liu K; Lin Q; Ding H; Jin Y; Chen G Int J Clin Exp Med; 2015; 8(11):20918-24. PubMed ID: 26885019 [TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357 [TBL] [Abstract][Full Text] [Related]
8. Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis. Wang H; Gao X; Zhang X; Gong W; Peng Z; Wang B; Wang L; Chang S; Ma P; Wang S Med Sci Monit; 2018 Oct; 24():7482-7492. PubMed ID: 30341887 [TBL] [Abstract][Full Text] [Related]
9. Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients. Ye H; Shao M; Shi X; Wu L; Xu B; Qu Q; Qu J Sci Rep; 2017 Jun; 7(1):2670. PubMed ID: 28572675 [TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population. Chen JB; Wang F; Wu JJ; Cai M Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525853 [TBL] [Abstract][Full Text] [Related]
11. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358 [TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644 [TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Safarinejad MR; Shafiei N; Safarinejad SH Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008 [TBL] [Abstract][Full Text] [Related]
15. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Schneider J; Bernges U; Philipp M; Woitowitz HJ Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047 [TBL] [Abstract][Full Text] [Related]
16. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer. Wang X; Huang ZH Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960 [TBL] [Abstract][Full Text] [Related]
17. Predictive potential role of glutathione S-transferases polymorphisms in response to chemotherapy and breast cancer prognosis. Yuan P; Yuan L; Xu BL; Wang CZ; Yang HZ; Li Y Genet Mol Res; 2015 Dec; 14(4):16675-81. PubMed ID: 26681014 [TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998 [TBL] [Abstract][Full Text] [Related]
19. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcomes of patients with advanced non-small cell lung cancer. Liu JY; Liu QM; Li LR Genet Mol Res; 2015 Aug; 14(3):10331-7. PubMed ID: 26345972 [TBL] [Abstract][Full Text] [Related]
20. Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics. Liu HF; Liu JS; Deng JH; Wu RR Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]